206997-15-1Relevant articles and documents
CB2-selective cannabinoid receptor ligands: Synthesis, pharmacological evaluation, and molecular modeling investigation of 1,8-naphthyridin-2(1 H)-one-3-carboxamides
Lucchesi, Valentina,Hurst, Dow P.,Shore, Derek M.,Bertini, Simone,Ehrmann, Brandie M.,Allarà, Marco,Lawrence, Lyle,Ligresti, Alessia,Minutolo, Filippo,Saccomanni, Giuseppe,Sharir, Haleli,Macchia, Marco,Di Marzo, Vincenzo,Abood, Mary E.,Reggio, Patricia H.,Manera, Clementina
, p. 8777 - 8791 (2014)
We have recently identified 1,8-naphthyridin-2(1H)-one-3-carboxamide as a new scaffold very suitable for the development of new CB2 receptor potent and selective ligands. In this paper we describe a number of additional derivatives in which the same central scaffold has been variously functionalized in position 1 or 6. All new compounds showed high selectivity and affinity in the nanomolar range for the CB2 receptor. Furthermore, we found that their functional activity is controlled by the presence of the substituents at position C-6 of the naphthyridine scaffold. In fact, the introduction of substituents in this position determined a functionality switch from agonist to antagonists/inverse agonists. Finally, docking studies showed that the difference between the pharmacology of these ligands may be in the ability/inability to block the Toggle Switch W6.48(258) (χ1 g+ → trans) transition.
CHEMICAL COMPOUNDS AS H-PGDS INHIBITORS
-
Page/Page column 65, (2019/01/08)
A compound of formula (I) wherein R1, R2, R3, R4, X, Y, and A are as defined herein. The compounds of the present invention are inhibitors of hematopoietic prostaglandin D synthase (H-PGDS) and can be useful in the treatment of Duchenne muscular dystrophy. Accordingly, the invention is further directed to pharmaceutical compositions comprising a compound of the invention. The invention is still further directed to methods of inhibiting H-PGDS activity and treatment of disorders associated therewith using a compound of the invention or a pharmaceutical composition comprising a compound of the invention.
AMINOPYRIDINE DERIVATIVES AS TAM FAMILY KINASE INHIBITORS
-
Page/Page column 61-62, (2015/06/11)
Provided herein are aminopyridine derivatives and pharmaceutical compositions that are useful as TAM family kinase inhibitors.